STRATEC Biomedical's total assets for Q3 2024 were €450.84M, an increase of 0.91% from the previous quarter. DE:SBS total liabilities were €223.08M for the fiscal quarter, a 1.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.